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Introduction 
Sinonasal undifferentiated carcinoma (SNUC) was 
first described in 1986, recognising it as a distinct 
clinicopathological entity more aggressive than 
other tumours with similar poorly-differentiated 
microscopic appearance, thus highlighting the 
importance of its identification (1). The main 
differential diagnoses of SNUC and small round 
cell tumour of sinonasal region are olfactory 
neuroblastoma and neuroendocrine carcinoma 
(both having favourable prognosis) (1) and 
malignant melanoma of the sinonasal region.  
The description of a rare histological variant by 
Jeng et al. (2) has further categorized 
undifferentiated carcinomas into sinonasal 
undifferentiated carcinoma (SNUC) and primary 
sinonasal nasopharyngeal-type undifferentiated 
carcinoma (PSNPC) which differ also in their 
association with Epstein-Barr Virus (EBV) 
infection and response to radiotherapy. 
Previous studies have demonstrated an association 
between EBV and development of SNUC, (3-5) 
however Cerilli et al. (6) reported the absence of 
this association in their series of twenty five cases. 
The diagnosis of these tumours is difficult on the 
basis of light microscopic features, therefore, 
immunohistochemical analysis of undifferentiated 
carcinomas of the sinonasal region has proven 
helpful in distinguishing this heterogenous group 
of malignancies, guiding the multidisciplinary team 
of clinicians in its management (7). 
Case report 
A 32-year old woman with no known medical 
illness presented to the Otorhinolaryngology-Head 
and Neck Surgery (ORL-HNS) outpatient clinic 
with a progressive bilateral nasal obstruction of 6 
duration, initially affecting the right side. The 
patient   had   2   weeks   history   of   intermittent 
epistaxis prior to presentation. There was no 
evidence of cranial nerve palsies, intracranial 
space-occupying lesions, head neck 
lymphadenopathy, and neither any oral cavity nor 
oropharyngeal masses. 
ABSTRACT 
Primary sinonasal nasopharyngeal-type undifferentiated carcinoma (PSNPC) is a rare variant of the sinonasal 
undifferentiated carcinoma (SNUC). The histological classification has implications on its management. 
We report a case of a 32 year old lady who presented with progressive nasal obstruction due to a sinonasal tumour. 
Endoscopic excision was performed and examination confirmed PSNPC with positive Epstein Barr virus in-situ 
hybridisation. 
Identification and recognition of PSNPC as a separate clinicopathological entity from SNUC is important as it dictates the 
management of this rare variant. Immunohistochemical analysis is invaluable in this endeavor. 
Key Words: Paranasal sinus, sinonasal, undifferentiated carcinoma, Epstein-Barr virus, nasopharynx  
 
Zahedi et al / EBV linked sinonasal undifferentiated carcinoma 
 
 
 
East J Med Volume:22, Number:2, April-June/2017 
 
71 
        
 
 
 
 
 
Her father was diagnosed and died of malignancy 
affecting the nasal cavity with neck 
lymphadenopathy. 
Rigid nasendoscopy revealed a mass completely 
occupying the nasopharynx which appeared to be 
arising from the postero-inferior part of the nasal 
septum. 
MRI of the paranasal sinuses and brain showed a 
large solid mass approximately 6 x 3 x 5 cm (AP x 
W x CC) with multiple areas of cystic 
degenerations arising from the nasal septum, 
occupying both nasal cavities with local 
infiltration of the roof of the nasopharynx, 
sphenoid sinuses and basisphenoid with 
dehiscence of sella turcica (Figure 1). 
Superolaterally, the tumour extends via the right 
foramen lacerum into the middle cranial fossa 
with discontinuity of the dura and encasement of 
petrous parts of both carotid arteries. There were 
bilateral subcentimeter level IIa and IIb lymph 
nodes. CT of the paranasal sinuses demonstrated 
calcifications within the mass, and extensive bony 
destruction of the basisphenoid (Figure 2). 
Incisional biopsy of the mass was performed and 
examination showed undifferentiated, non-
keratinizing malignant epithelial cells infiltrating 
the stroma in a syncytial pattern. 
Immunohistochemical analysis showed strong 
cytokeratin positivity (CK 5/6), negative for S100 
and synaptophysin, but strongly and 
homogenously positive for EBV RNA in-situ 
hybridisation (Figures 3-6). 
Pitman et al. (8) reported that combined surgical 
therapy of similar lesions, previously considered 
unresectable has increased the rate. She 
subsequently underwent a formal nasendoscopic 
excision of the sinonasal tumour, with functional 
endoscopic sinus surgery - posterior septectomy, 
ethmoidectomy, middle meatal antrostomy, 
nasopharyngectomy, debridement of the 
infiltrated clivus, and repair of the dural defects in 
the sella and clivus with dural tissue. 
Intraoperatively, there was no evidence of tumour 
involvement of the pituitary gland. She had an 
uneventful and uncomplicated post-operative 
recovery period.  
The HPE of the excisional biopsies were 
consistent with the findings of the preceding 
incisional biopsy. 
As this tumour is extremely rare, there is lack of 
published evidence on the specific treatment plan 
for such malignancies. The patient underwent 
intensity-modulated radiotherapy (IMRT) post-
operatively. 
CT paranasal sinuses 5 months post-operatively 
confirmed residual tumour with extensive skull 
base destruction and left neck nodal metastases. 
Fig. 1. MRI (coronal) showing the septal mass with 
multiple areas of cystic degeneration, occupying both 
nasal cavities. 
 
Fig. 2. CT scan (sagittal) showing the mass centred 
around the destructed nasal septum with amorphous 
linear calcification within the mass. There is evidence 
of erosion of the floor of the sphenoid sinus with 
involvement of the dorsum sella.  
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Discussion 
Carcinoma of the nasal cavities and paranasal 
sinuses rare (less than 1% of all malignancies and 
only 3% of head and neck malignancies). 
Squamous cell carcinomas (both keratinizing and 
non-keratinizing types) are the most commonly 
occuring malignant neoplasm in the sinonasal 
tract. 
The more aggressive, high-grade undifferentiated 
malignant neoplasm of epithelial origin can occur, 
albeit less frequently than SCCs, was first 
described by Frierson et al (1). Differentiation of 
undifferentiated epithelial from non-epithelial 
malignant neoplasms has been made possible with 
immunohistochemical markers such as the 
cytokeratins. 
Differential diagnoses for undifferentiated 
sinonasal tract malignancies include, SNUC, 
olfactory neuroblastoma, small cell 
undifferentiated (neuroendocrine) carcinoma, 
mucosal malignant melanoma, 
rhabdomyosarcoma, hematolymphoid 
malignancies (nasal-type T/NK-cell lymphoma), 
primitive neuroectodermal tumour/Ewing 
sarcoma and primary sinonasal nasopharyngeal-
type undifferentiated carcinoma (PSNPC), also 
known as lymphoepithelial carcinoma (2,7). 
The latter was described by Jeng et al. (2) in 2002 
who recognised that despite SNUC and PSNPC 
both being undifferentiated and of epithelial 
origin, with similarities in microscopic appearance 
confirmed PSNPC is a separate clinicopathological 
entity from SNUC and an accepted WHO 
classification (6,7). This rare variant is closely 
related and has a histological resemblance to 
nasopharyngeal carcinoma, with most cases 
reported (13 reported cases in the literature) in the 
far East (2, 6, 9). 
Figures 3 and 4. Low power view showing the tumour cells arranged in syncytial pattern with areas of 
haemorrhages seen. 
Figures 5 and 6. The tumour cells exhibit medium sized, oval to spindle shape, vesicular to hyperchromatic nuclei 
with some showing prominent nucleoli. There are lymphoplasmacytic infiltrates in between the tumour cells. 
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Key cytological features of PSNPC is medium-
sized oval to spindle-shaped cells, enlarged nuclei, 
vesicular chromatin and prominent nucleoli.  
Indistinct cell borders with a syncytial growth 
pattern, limited mitotic activity, mild to moderate 
(less than in NPC) lymphoplasmacytic cell 
infiltrate, and usually absence of necrosis and 
keratinization are features identifiable in PSNPC 
which enables its differentiation from SNUC. 
Presence of EBV upon EBV-RNA in-situ 
hybridisation also differentiates PSNPC (3-5). 
Our case demonstrated histopathological, 
immunohistochemical and EBER-positive features 
consistent with those described by Jeng et al. (2) 
and thus far has a similar survival outcome 
matched to the cases in their series, with similar-
staged disease. 
In a conclusion, Epstein-Barr virus positive 
PSNPC is a highly aggressive rare variant of 
SNUC. Despite combined surgical techniques 
allowing surgical resection of these tumours that 
tend to be in advanced stages at presentation, the 
risk of recurrence is high. Patients should undergo 
post-operative radiotherapy for improved local 
control. Regular post-operative clinical and 
radiological surveillance is vital. 
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